NCT02173964View on ClinicalTrials.gov

Pinverin Application Trial to Reduce Bowel Uptake of FDG (Fluorodeoxyglucose)

PHASE4CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Cancer
Interventions
DRUG

pinaverium bromide

pinverin 50 mg per oral single dose versus simple water ingestion

DRUG

water

same amount of water for pinverin administration

Trial Locations (1)

463-707

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT02173964 - Pinverin Application Trial to Reduce Bowel Uptake of FDG (Fluorodeoxyglucose) | Biotech Hunter | Biotech Hunter